Dr. Lal PathLabs Ltd (BOM:539524)
₹ 1,892.7 +4.2 (+0.22%) Market Cap: 316.85 Bil Enterprise Value: 305.86 Bil PE Ratio: 58.28 PB Ratio: 12.57 GF Score: 97/100

Q1 2020 Dr. Lal PathLabs Ltd Earnings Call Transcript

Aug 13, 2019 / 11:00AM GMT
Release Date Price: ₹534.9 (-2.02%)
Operator

Ladies and gentlemen, good day, and welcome to Dr. Lal PathLabs Q1 FY '20 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nishid Solanki of CDR India. Thank you, and over to you, sir.

Nishid Solanki
CDR India - IR Manager

Thank you. Good afternoon, everyone, and a warm welcome to Dr. Lal PathLabs' Q1 FY '20 earnings conference call. Joining us today are Honorary Brigadier Dr. Arvind Lal, Chairman and Managing Director; Dr. Om Prakash Manchanda, Whole Time Director and CEO; Mr. Ved Prakash Goel, CFO. We also have with us Mr. Bharath, CEO, India business; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Before we begin the call, I would like to highlight that some of the statements made on the call today could be forward-looking in nature. Actual results may vary from these statements. A detailed disclosure in this regard is available in the results presentation, which was circulated to you earlier.

I would now like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot